Gaballa, S., Ge, I., Fakih, R. E., Brammer, J. E., Kongtim, P., Tomuleasa, C., . . . Ciurea, S. O. (2016). Results of a 2-Arm, Phase 2 Clinical Trial Using Post-Transplantation Cyclophosphamide for the Prevention of Graft-Versus-Host Disease in Haploidentical Donor and Mismatched Unrelated Donor Hematopoietic Stem Cell Transplantation. Cancer.
Chicago Style CitationGaballa, Sameh, et al. "Results of a 2-Arm, Phase 2 Clinical Trial Using Post-Transplantation Cyclophosphamide for the Prevention of Graft-Versus-Host Disease in Haploidentical Donor and Mismatched Unrelated Donor Hematopoietic Stem Cell Transplantation." Cancer 2016.
Cita MLAGaballa, Sameh, et al. "Results of a 2-Arm, Phase 2 Clinical Trial Using Post-Transplantation Cyclophosphamide for the Prevention of Graft-Versus-Host Disease in Haploidentical Donor and Mismatched Unrelated Donor Hematopoietic Stem Cell Transplantation." Cancer 2016.